Peer-reviewed veterinary case report
Treating eye problems in cats with feline infectious peritonitis
By Andrews, Amy L M M et al.·Published in Journal of veterinary internal medicine·2025·Department of Clinical Science and Research, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Treatment With Remdesivir Alone or in Combination With GS-441524 in Cats With Ocular Involvement of Feline Infectious Peritonitis: An Observational Case Series.
- Species:
- cat
Plain-English summary
A group of 61 cats diagnosed with feline infectious peritonitis (FIP) showed signs of eye problems, specifically uveitis, which is inflammation of the eye. Most of these cats were treated with remdesivir, an antiviral medication, and many received a high dose. After an 84-day treatment period, 82% of the cats with eye inflammation saw improvement, and overall, 80% of the cats survived. This suggests that antiviral treatments can effectively help with eye issues related to FIP in cats.
People also search for: cat eye problems FIP treatment · feline infectious peritonitis symptoms · remdesivir for cats eye inflammation
Abstract
BACKGROUND: Remdesivir and GS-441524 have successfully treated cats with feline infectious peritonitis (FIP) but the changes in associated signs of ocular disease are not reported. OBJECTIVE: Evaluate the response of FIP-associated signs of ocular disease before and after treatment with remdesivir, GS-441524, or both. ANIMALS: Sixty-one cats diagnosed with FIP by the Internal Medicine services between October 2021 and December 2022 that were treated with injectable, oral, or a combination of anti-viral therapies were reviewed. METHODS: Observation study. Signalment, associated signs of ocular disease, treatment, outcome, and follow-up of affected cats were analyzed. RESULTS: Associated signs of ocular disease in cats with FIP were diagnosed in 33% (20/61) cats, with a median follow-up of 55 days (IQR 47.3-90.8, range: 16-1071 days) in 11 cats with FIP. Ocular changes were all associated with uveitis, of which 20% (4/20) had anterior uveitis, 25% (5/20) had posterior uveitis, and 55% (11/20) had panuveitis. Ocular disease occurred in effusive (11/20; 55%) and non-effusive (9/20; 45%) FIP and was bilateral in 70% (14/20) cats. All cats started an 84-day course of treatment, with the majority (17/20; 85%) receiving remdesivir in the initial period. Of those, 70% (12/17) received a high dose of 15-20 mg/kg/day. Eleven cats with uveitis had long-term follow-up nine (9/11; 82%) of these had resolution of uveitis. Eighty-seven percent (13/15) of cases with anterior uveitis received topical anti-inflammatory medication. Eighty percent (16/20) of cats survived. CONCLUSION AND CLINICAL IMPORTANCE: Cats with FIP commonly have ocular involvement. Associated uveitis responded to remdesivir or GS-441524 treatment effectively in 82% of cases.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41035288/